North America Interventional Cardiology Market Outlook to 2025

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$5995
Buy Report

Published: April 15, 2018 Report Code: GDMECR0799DB-ST

Select Item

“What is covered in the report about the “North America Interventional Cardiology Market”?
GlobalData’s “North America Interventional Cardiology Market Outlook to 2025” report is a comprehensive databook report, covering key market data on the North America Interventional Cardiology market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Arteriotomy Closure Devices, Cardiac Catheters, Coronary Guidewires, Coronary Stents, Intravascular Ultrasound Systems (IVUS), PTCA Balloons Catheters and PTCA Drug Eluting Balloon (DEB) Catheters

The North America Interventional Cardiology Market report provides key information and data on
• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2015 to 2025.
• 2017 company share and distribution share data for Interventional Cardiology market.
• Global corporate-level profiles of key companies operating within the North America Interventional Cardiology Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

North America Interventional Cardiology is segmented as follows:
• Arteriotomy Closure Devices
• Cardiac Catheters
• Coronary Guidewires
• Coronary Stents
• Intravascular Ultrasound Systems (IVUS)
• PTCA Balloons Catheters
• PTCA Drug Eluting Balloon (DEB) Catheters
Key Reasons to Purchase
The North America Interventional Cardiology Market report helps you to develop
• Business strategies by identifying the key market segments poised for strong growth in the future.
• Market-entry and market expansion strategies.
• Design competition strategies by identifying who-stands-where in the market.
• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
• Understand the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Key companies covered in the “North America Interventional Cardiology Market Outlook to 2025” report
• Abbott Laboratories
• Boston Scientific Corp
• Medtronic plc

The GlobalData Differentiation
Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.
The data and analysis within this report are driven by GlobalData Medical Equipment (GDME) databases. GlobalData Medical Equipment database gives you the key information required to drive sales, investment and deal-making activity in your business. It includes the following:
• 15,000+ data tables showing market size across more than 780 medical equipment segments and 39 countries, from 2015 and forecast to 2025
• 15,000+ primary interviews, conducted annually to ensure data and report quality
• 2,000+ industry-leading analysis and procedure reports covering growing sectors, market trends, investment opportunities and competitive landscape
• 61,791+ medical equipment company profiles
• 4,300+ company profiles of medical equipment manufacturers in China and India
• 825+ companies’ revenue splits and market shares
• 1,900+ quarterly and annual medical equipment company financials
• 940+ medical equipment company SWOTs
• 24,300+ pipeline product profiles
• 43,200+ marketed product profiles
• 39,200+ clinical trials
• 44,900+ trial investigators
• 6,700+ reports on companies with products in development
• 38,300+ deals in the medical equipment industry
• 1,300+ surgical and diagnostic procedures by therapy area
• 50+ key healthcare indicators by country

For more information or to receive a free demonstration of the service, please visit:
http://globaldata.com/medical/Home.aspx

Custom Requirements
Contact us to discuss the areas of your business where you need external input, and we will work with you to identify the strongest way forward to meet your needs.

Scope

NA

Table of Contents

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 7

1.2 List of Figures 8

2 Introduction 10

2.1 What Is This Report About? 10

2.2 Interventional Cardiology Market Segmentation 10

2.3 Definitions of Markets Covered in the Report 11

3 Interventional Cardiology Market, North America 15

3.1 Interventional Cardiology Market, North America, Revenue ($m), 2015-2025 15

3.2 Interventional Cardiology Market, North America, Revenue ($m), 2015-2025 17

3.3 Interventional Cardiology Market, North America, Volume (Units), 2015-2025 20

3.4 Interventional Cardiology Market, North America, Volume (Units), 2015-2025 22

3.5 Interventional Cardiology Market, North America, Company Share by Revenue ($m), 2017 25

4 Interventional Cardiology Market, Canada 27

4.1 Interventional Cardiology Market, Canada, Revenue ($m), 2015-2025 27

4.1.1 Arteriotomy Closure Devices Market, Canada, Revenue ($m), by Segment, 2015-2025 30

4.1.2 Cardiac Catheters Market, Canada, Revenue ($m), by Segment, 2015-2025 32

4.1.3 Coronary Stents Market, Canada, Revenue ($m), by Segment, 2015-2025 34

4.1.4 Intravascular Ultrasound Systems (IVUS) Market, Canada, Revenue ($m), by Segment, 2015-2025 37

4.1.5 PTCA Balloons Catheters Market, Canada, Revenue ($m), by Segment, 2015-2025 39

4.2 Interventional Cardiology Market, Canada, Volume (Units), 2015-2025 41

4.2.1 Arteriotomy Closure Devices Market, Canada, Volume (Units), by Segment, 2015-2025 44

4.2.2 Cardiac Catheters Market, Canada, Volume (Units), by Segment, 2015-2025 46

4.2.3 Coronary Stents Market, Canada, Volume (Units), by Segment, 2015-2025 48

4.2.4 Intravascular Ultrasound Systems (IVUS) Market, Canada, Volume (Units), by Segment, 2015-2025 51

4.2.5 PTCA Balloons Catheters Market, Canada, Volume (Units), by Segment, 2015-2025 53

4.3 Interventional Cardiology Market, Canada, Average Price ($), 2015-2025 55

4.4 Interventional Cardiology Market, Canada, Distribution Share by Revenue ($m), 2017 59

4.5 Interventional Cardiology Market, Canada, Company Share by Revenue ($m), 2017 60

5 Interventional Cardiology Market, Mexico 62

5.1 Interventional Cardiology Market, Mexico, Revenue ($m), 2015-2025 62

5.1.1 Arteriotomy Closure Devices Market, Mexico, Revenue ($m), by Segment, 2015-2025 65

5.1.2 Cardiac Catheters Market, Mexico, Revenue ($m), by Segment, 2015-2025 67

5.1.3 Coronary Stents Market, Mexico, Revenue ($m), by Segment, 2015-2025 69

5.1.4 Intravascular Ultrasound Systems (IVUS) Market, Mexico, Revenue ($m), by Segment, 2015-2025 72

5.1.5 PTCA Balloons Catheters Market, Mexico, Revenue ($m), by Segment, 2015-2025 74

5.2 Interventional Cardiology Market, Mexico, Volume (Units), 2015-2025 76

5.2.1 Arteriotomy Closure Devices Market, Mexico, Volume (Units), by Segment, 2015-2025 79

5.2.2 Cardiac Catheters Market, Mexico, Volume (Units), by Segment, 2015-2025 81

5.2.3 Coronary Stents Market, Mexico, Volume (Units), by Segment, 2015-2025 83

5.2.4 Intravascular Ultrasound Systems (IVUS) Market, Mexico, Volume (Units), by Segment, 2015-2025 86

5.2.5 PTCA Balloons Catheters Market, Mexico, Volume (Units), by Segment, 2015-2025 88

5.3 Interventional Cardiology Market, Mexico, Average Price ($), 2015-2025 90

5.4 Interventional Cardiology Market, Mexico, Distribution Share by Revenue ($m), 2017 94

5.5 Interventional Cardiology Market, Mexico, Company Share by Revenue ($m), 2017 95

6 Interventional Cardiology Market, United States 97

6.1 Interventional Cardiology Market, United States, Revenue ($m), 2015-2025 97

6.1.1 Arteriotomy Closure Devices Market, United States, Revenue ($m), by Segment, 2015-2025 100

6.1.2 Cardiac Catheters Market, United States, Revenue ($m), by Segment, 2015-2025 102

6.1.3 Coronary Stents Market, United States, Revenue ($m), by Segment, 2015-2025 104

6.1.4 Intravascular Ultrasound Systems (IVUS) Market, United States, Revenue ($m), by Segment, 2015-2025 107

6.1.5 PTCA Balloons Catheters Market, United States, Revenue ($m), by Segment, 2015-2025 109

6.2 Interventional Cardiology Market, United States, Volume (Units), 2015-2025 111

6.2.1 Arteriotomy Closure Devices Market, United States, Volume (Units), by Segment, 2015-2025 114

6.2.2 Cardiac Catheters Market, United States, Volume (Units), by Segment, 2015-2025 116

6.2.3 Coronary Stents Market, United States, Volume (Units), by Segment, 2015-2025 118

6.2.4 Intravascular Ultrasound Systems (IVUS) Market, United States, Volume (Units), by Segment, 2015-2025 121

6.2.5 PTCA Balloons Catheters Market, United States, Volume (Units), by Segment, 2015-2025 123

6.3 Interventional Cardiology Market, United States, Average Price ($), 2015-2025 125

6.4 Interventional Cardiology Market, United States, Distribution Share by Revenue ($m), 2017 129

6.5 Interventional Cardiology Market, United States, Company Share by Revenue ($m), 2017 130

7 Overview of Key Companies in North America Interventional Cardiology Market 132

7.1 Boston Scientific Corp 132

7.1.1 Company Overview 132

7.2 Abbott Laboratories 132

7.2.1 Company Overview 132

7.3 Medtronic Plc 132

7.3.1 Company Overview 132

7.4 Terumo Corp 132

7.4.1 Company Overview 132

7.5 Cook Medical Inc 133

7.5.1 Company Overview 133

7.6 Philips Healthcare 133

7.6.1 Company Overview 133

7.7 Asahi Kasei Corp 133

7.7.1 Company Overview 133

7.8 Cardinal Health Inc 133

7.8.1 Company Overview 133

8 Interventional Cardiology Market Pipeline Products 134

9 Recent Developments 137

9.1 Corporate Communications 137

9.1.1 Mar 30, 2018: Abiomed to Appoint New Chief Financial Officer Todd A. Trapp 137

9.1.2 Feb 27, 2018: Z-Medica Announces Appointment Of Eric Compton As CEO 137

9.1.3 Feb 21, 2018: Endologix Announces Resignation Of John McDermott As Chief Executive Officer 137

9.1.4 Feb 20, 2018: AtriCure Names Scott Drake Board Chairman 138

9.1.5 Feb 12, 2018: Integer Elects James Hinrichs to its Board of Directors 138

9.1.6 Feb 02, 2018: Cardiovascular Systems Appoints Jeff Points as Chief Financial Officer 139

9.1.7 Jan 29, 2018: Endologix Names Greg Morrow As Chief Marketing Officer 139

9.1.8 Jan 29, 2018: Endologix Appoints Greg Morrow as Chief Marketing Officer 140

9.1.9 Jan 24, 2018: Cardiovascular Systems Appoints Rhonda Robb as New Chief Operating Officer 140

9.1.10 Jan 22, 2018: Neovasc Appoints Fred Colen As Chief Executive Officer 141

9.1.11 Jan 03, 2018: Tryton Medical Announces New CEO and President 142

9.1.12 Jan 02, 2018: Integer Names Kirk Thor Chief Human Resources Officer 142

9.1.13 Nov 22, 2017: IMRIS Appoints Mark Strong as Senior Vice President – Research & Development 142

9.1.14 Nov 20, 2017: Follicum applies for the start of a Phase II study at the German Medicines Agency 143

9.1.15 Oct 31, 2017: Luminex Corporation Receives FDA Clearance for ARIES Group A Strep Assay 143

9.1.16 Oct 19, 2017: Endologix Appoints John Onopchenko as Chief Operating Officer 145

9.1.17 Oct 04, 2017: Boston Scientific Appoints Desiree Ralls-Morrison General Counsel and Corporate Secretary 145

9.1.18 Oct 02, 2017: Jeffrey H. Burbank Joins CryoLife Board of Directors 146

9.1.19 Sep 26, 2017: Edward Parent Appointed Director of Quality Assurance at TissueGen 146

9.1.20 Aug 28, 2017: Abiomed Announces Resignation of Chief Financial Officer and Welcomes Back Former Chief Financial Officer as Consultant 147

9.1.21 Aug 08, 2017: John K. Bakewell Joins Corindus Vascular Robotics Board of Directors 147

9.1.22 Jul 31, 2017: Atara Biotherapeutics Announces Two Presentations at MSParis2017, Including Updated, Interim Results from a Phase 1 Study of Autologous ATA188 in Patients with Progressive Multiple Sclerosis 148

9.1.23 Jul 18, 2017: AtriCure Announces Hiring of Chief Technology Officer 149

9.1.24 Jul 17, 2017: Integer Announces Appointment of Joseph W. Dziedzic as President and Chief Executive Officer 149

9.1.25 Jun 20, 2017: Medtronic VP and GM Sandra Lesenfants Joins Osprey Board 150

9.1.26 Jun 20, 2017: Medtronic VP and GM Sandra Lesenfants J oins Osprey Board 150

9.1.27 Jun 14, 2017: Spectranetics Announces Election of New Chairperson of the Board of Directors 151

9.1.28 May 26, 2017: Merit Medical Announces Appointment of New Director 151

9.1.29 Apr 19, 2017: TissueGen appoints New Faces for Growing Sales Team 151

9.2 Financial Announcements 152

9.2.1 Mar 29, 2018: AngioDynamics Reports Fiscal 2018 Third Quarter Financial Results 152

9.2.2 Mar 28, 2018: Neovasc Announces Results for the Fourth Quarter and Fiscal Year 2017 153

9.2.3 Mar 14, 2018: Corindus Reports Fourth Quarter and Full Year 2017 Results 155

9.2.4 Mar 07, 2018: CryoLife Reports Fourth Quarter and Full Year 2017 Results 156

9.2.5 Feb 26, 2018: AtriCure Announces Fourth Quarter and Full Year 2017 Financial Results 157

9.2.6 Feb 22, 2018: Integer Holdings Reports Results for Fourth Quarter and Full Year 2017 158

9.2.7 Feb 21, 2018: Endologix Reports Fourth Quarter and Fiscal Year 2017 Financial Results 159

9.2.8 Feb 20, 2018: Philips increases Green Revenues to EUR

10.7 billion, 60% of total sales in 2017 160

9.2.9 Feb 08, 2018: Surmodics Reports First Quarter Fiscal 2018 Results, Updates Fiscal 2018 Guidance 160

9.2.10 Feb 07, 2018: Cardiovascular Systems Reports Fiscal 2018 Second-Quarter Financial Results 161

9.2.11 Feb 01, 2018: Boston Scientific Announces Results for Fourth Quarter and Full Year 2017 162

9.2.12 Feb 01, 2018: Abiomed Announces Q3 FY 2018 Record Revenue of $154 Million, Up 34% Over Prior Year 164

9.2.13 Jan 23, 2018: Glytec's Software Yields Superior Patient Outcomes According to Four New Studies in Journal of Diabetes Science and Technology 164

9.2.14 Jan 09, 2018: Boston Scientific Announces Preliminary Unaudited Sales For The Fourth Quarter And Full Year Ended December 31, 2017 166

9.2.15 Jan 08, 2018: AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2017 166

9.2.16 Jan 08, 2018: Abiomed Announces Preliminary Q3 FY 2018 Revenue of $154M, Up 34% Over Prior Year 166

9.2.17 Jan 04, 2018: AngioDynamics Reports Fiscal 2018 Second Quarter Financial Results 167

9.2.18 Dec 12, 2017: Cyclacel Announces Presentation of Results From Phase 3 Seamless Study at Ash Annual Meeting 168

9.2.19 Nov 14, 2017: Neovasc Announces Results for the Third Quarter of 2017 169

9.2.20 Nov 08, 2017: Surmodics Reports Fourth Quarter Fiscal 2017 Results and Provides Fiscal 2018 Guidance 171

9.2.21 Nov 07, 2017: Endologix Reports Third Quarter 2017 Financial Results 172

9.2.22 Nov 07, 2017: Corindus Vascular Robotics Reports Third Quarter 2017 Results 173

9.2.23 Nov 01, 2017: AtriCure Reports Third Quarter 2017 Financial Results 173

9.2.24 Oct 31, 2017: Abbott Announces FDA Clearance for its Alinity ci-series Next-generation Diagnostic Systems 174

9.2.25 Oct 31, 2017: Northwell expands technology that precisely targets breast tumors 176

9.2.26 Oct 30, 2017: CryoLife Reports Third Quarter 2017 Results 178

9.2.27 Oct 26, 2017: Abiomed Announces Q2 FY 2018 Revenue of $132.8 Million, Up 29% and Record U.S. Patient Utilization, Up 33% 180

9.2.28 Oct 26, 2017: Boston Scientific Announces Results For Third Quarter 2017 180

9.2.29 Oct 26, 2017: Integer Holdings Reports Third Quarter 2017 Results 182

9.2.30 Oct 25, 2017: Cardiovascular Systems Reports Fiscal 2018 First-Quarter Financial Results 183

9.2.31 Oct 25, 2017: Merit Medical Reports Results for Third Quarter 2017 184

9.2.32 Sep 28, 2017: AngioDynamics Reports Fiscal 2018 First Quarter Results 185

9.2.33 Aug 15, 2017: CareRay Exhibits At FIME 2017 186

9.2.34 Aug 10, 2017: Neovasc Announces Results for the Second Quarter of 2017 187

9.2.35 Aug 08, 2017: Corindus Vascular Robotics Reports Second Quarter 2017 Results 189

9.2.36 Aug 03, 2017: Surmodics Reports Third Quarter Fiscal 2017 Results and Updates Fiscal 2017 Guidance 190

9.2.37 Aug 03, 2017: Spectranetics Reports Second Quarter 2017 Revenue of $74.7 million 190

9.2.38 Aug 02, 2017: Cardiovascular Systems Reports Fiscal 2017 Fourth-Quarter Financial Results 191

9.2.39 Aug 02, 2017: Endologix Reports Second Quarter 2017 Financial Results 192

9.2.40 Jul 27, 2017: Boston Scientific Announces Results for Second Quarter 2017 193

9.2.41 Jul 27, 2017: AtriCure Reports Second Quarter 2017 Financial Results 194

9.2.42 Jul 27, 2017: Abiomed Announces Q1 FY 2018 Revenue of $132.5 Million, Up 29% Over Prior Year 195

9.2.43 Jul 27, 2017: Integer Holdings Reports Second Quarter 2017 Results 196

9.2.44 Jul 26, 2017: Merit Medical Reports Record Revenue and Non-GAAP Net Income for Second Quarter 2017, Raises 2017 Guidance and Gives Preliminary 2018-2019 Guidance 197

9.2.45 Jul 24, 2017: CryoLife Reports Second Quarter 2017 Financial Results 198

9.2.46 Jul 18, 2017: AngioDynamics Reports Fiscal 2017 Fourth Quarter and Full-Year Results 199

9.2.47 May 10, 2017: Neovasc Announces Results for the First Quarter of 2017 200

9.2.48 May 09, 2017: Corindus Vascular Robotics Reports First Quarter 2017 Results 202

9.2.49 May 08, 2017: Integer Holdings Reports First Quarter 2017 Results 203

9.2.50 May 04, 2017: AtriCure Reports First Quarter 2017 Financial Results 204

9.2.51 May 04, 2017: Abiomed Announces Q4 FY 2017 Revenue of $124.7 Million, Up 33% Over Prior Year and Total Year Revenue of $445.3 Million, Up 35% Over Prior Year 204

9.2.52 May 04, 2017: Endologix Reports First Quarter 2017 Financial Results 205

9.2.53 May 03, 2017: Cardiovascular Systems Reports Fiscal 2017 Third-Quarter Financial Results 206

9.2.54 Apr 27, 2017: Boston Scientific Announces Results For First Quarter 2017 207

9.2.55 Apr 27, 2017: Surmodics Reports Second Quarter Fiscal 2017 Results, Updates Fiscal 2017 Financial Guidance 208

9.2.56 Apr 27, 2017: Merit Medical Reports Results for First Quarter of 2017 209

9.2.57 Apr 27, 2017: Spectranetics Reports First Quarter 2017 Revenue of $69.7 million 210

9.2.58 Apr 26, 2017: CryoLife Reports First Quarter 2017 Financial Results 210

9.2.59 Apr 20, 2017: bioMerieux: The FilmArray Respiratory Panel 2 plus (RP2plus) Gets CE Marked 211

9.2.60 Apr 17, 2017: Lixte Biotechnology's Protein Phosphatase 2A Inhibitor, LB-100, Reported to be a Potentiator of Immunotherapy in an Animal Model 213

9.2.61 Apr 17, 2017: Surmodics Appoints Lisa Wipperman Heine to Its Board of Directors 214

9.3 Government and Public Interest 214

9.3.1 Apr 03, 2018: Important JAMA Article Underscores Superiority of Precipio’s Liquid Biopsy Core Technology 214

9.3.2 Jul 19, 2017: NIDEK’s Me1200 won the "Ponts d’Or" award in France 215

9.4 Legal And Regulatory 216

9.4.1 Mar 13, 2018: Precipio Settles Lawsuit with Crede Capital 216

9.4.2 Nov 03, 2017: Neovasc Provides Litigation Update 217

9.4.3 Oct 18, 2017: Loxo Oncology Announces Positive Top-Line Results from Independent Review Committee Assessment of Larotrectinib Dataset 217

9.4.4 Sep 07, 2017: Ignyta To Host Conference Call And Live Webcast On September 11 To Provide Pipeline Review, Including Lead Candidate Entrectinib 218

9.5 Other Significant Developments 218

9.5.1 Feb 22, 2018: Integer Announces Strategy Focused on Portfolio Management and Operational Excellence; Aligns Senior Management to Execute Strategic Imperatives 218

9.5.2 Feb 08, 2018: IMRIS Reports Continued Strong Growth in 2017 219

9.5.3 Sep 18, 2017: Cardiovascular Systems Announces Anticipated Revenue Impact from Hurricanes Harvey and Irma 220

9.5.4 Jun 27, 2017: Boston Scientific Outlines Strategy for Sustained Growth at 2017 Investor Day 220

9.5.5 Apr 25, 2017: AtriCure's AtriClip System Surpasses 100,000 Units Sold Worldwide 221

9.6 Product News 222

9.6.1 Jan 02, 2018: Corindus to Participate with Mayo Clinic in Preclinical Study of Remote Control Robotics for Percutaneous Coronary Interventions Remote Treatment Capabilities 222

9.6.2 Oct 10, 2017: Allergan Announces that the FDA Accepts New Drug Application for Ulipristal Acetate for Uterine Fibroids 223

9.7 Strategy And Business Planning 224

9.7.1 Sep 26, 2017: MicroVention Celebrates Grand Opening of New Worldwide Innovation Center in Aliso Viejo, California 224

10 Appendix 225

10.1 Research Methodology 226

10.1.1 Coverage 226

10.1.2 Secondary Research 226

10.1.3 Primary Research 227

10.1.4 Market Modeling and Forecasting 228

10.1.5 Company Share Analysis 229

10.1.6 Distribution Share Analysis 230

10.1.7 Benchmarking 230

10.2 GlobalData Consulting 230

10.3 Contact Us 231

10.4 Disclaimer 231

Table

1.1 List of Tables

Table 1: Interventional Cardiology Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2015-2025 16

Table 2: Interventional Cardiology Market, North America, Revenue ($m), Historic, USD Constant, 2015-2020 18

Table 3: Interventional Cardiology Market, North America, Revenue ($m), Forecast, USD Constant, 2021-2025 19

Table 4: Interventional Cardiology Market, North America, Volume (Units), 2015-2025 21

Table 5: Interventional Cardiology Market, North America, Volume (Units), 2015-2020 23

Table 6: Interventional Cardiology Market, North America, Volume (Units), 2021-2025 24

Table 7: Interventional Cardiology Market, North America, Company Share by Revenue ($m), USD Constant, 2017 26

Table 8: Interventional Cardiology Market, Canada, Revenue ($m), USD Constant, 2015-2020 28

Table 9: Interventional Cardiology Market, Canada, Revenue ($m), USD Constant, 2021-2025 29

Table 10: Arteriotomy Closure Devices Market, Canada, Revenue ($m), USD Constant, 2015-2020 31

Table 11: Arteriotomy Closure Devices Market, Canada, Revenue ($m), USD Constant, 2021-2025 31

Table 12: Cardiac Catheters Market, Canada, Revenue ($m), USD Constant, 2015-2020 33

Table 13: Cardiac Catheters Market, Canada, Revenue ($m), USD Constant, 2021-2025 33

Table 14: Coronary Stents Market, Canada, Revenue ($m), USD Constant, 2015-2020 35

Table 15: Coronary Stents Market, Canada, Revenue ($m), USD Constant, 2021-2025 36

Table 16: Intravascular Ultrasound Systems (IVUS) Market, Canada, Revenue ($m), USD Constant, 2015-2020 38

Table 17: Intravascular Ultrasound Systems (IVUS) Market, Canada, Revenue ($m), USD Constant, 2021-2025 38

Table 18: PTCA Balloons Catheters Market, Canada, Revenue ($m), USD Constant, 2015-2020 40

Table 19: PTCA Balloons Catheters Market, Canada, Revenue ($m), USD Constant, 2021-2025 40

Table 20: Interventional Cardiology Market, Canada, Volume (Units), 2015-2020 42

Table 21: Interventional Cardiology Market, Canada, Volume (Units), 2021-2025 43

Table 22: Arteriotomy Closure Devices Market, Canada, Volume (Units), 2015-2020 45

Table 23: Arteriotomy Closure Devices Market, Canada, Volume (Units), 2021-2025 45

Table 24: Cardiac Catheters Market, Canada, Volume (Units), 2015-2020 47

Table 25: Cardiac Catheters Market, Canada, Volume (Units), 2021-2025 47

Table 26: Coronary Stents Market, Canada, Volume (Units), 2015-2020 49

Table 27: Coronary Stents Market, Canada, Volume (Units), 2021-2025 50

Table 28: Intravascular Ultrasound Systems (IVUS) Market, Canada, Volume (Units), 2015-2020 52

Table 29: Intravascular Ultrasound Systems (IVUS) Market, Canada, Volume (Units), 2021-2025 52

Table 30: PTCA Balloons Catheters Market, Canada, Volume (Units), 2015-2020 54

Table 31: PTCA Balloons Catheters Market, Canada, Volume (Units), 2021-2025 54

Table 32: Interventional Cardiology Market, Canada, Average Price ($), 2015-2020 55

Table 33: Interventional Cardiology Market, Canada, Average Price ($), 2021-2025 57

Table 34: Interventional Cardiology Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2017 59

Table 35: Interventional Cardiology Market, Canada, Company Share by Revenue ($m), USD Constant, 2017 61

Table 36: Interventional Cardiology Market, Mexico, Revenue ($m), USD Constant, 2015-2020 63

Table 37: Interventional Cardiology Market, Mexico, Revenue ($m), USD Constant, 2021-2025 64

Table 38: Arteriotomy Closure Devices Market, Mexico, Revenue ($m), USD Constant, 2015-2020 66

Table 39: Arteriotomy Closure Devices Market, Mexico, Revenue ($m), USD Constant, 2021-2025 66

Table 40: Cardiac Catheters Market, Mexico, Revenue ($m), USD Constant, 2015-2020 68

Table 41: Cardiac Catheters Market, Mexico, Revenue ($m), USD Constant, 2021-2025 68

Table 42: Coronary Stents Market, Mexico, Revenue ($m), USD Constant, 2015-2020 70

Table 43: Coronary Stents Market, Mexico, Revenue ($m), USD Constant, 2021-2025 71

Table 44: Intravascular Ultrasound Systems (IVUS) Market, Mexico, Revenue ($m), USD Constant, 2015-2020 73

Table 45: Intravascular Ultrasound Systems (IVUS) Market, Mexico, Revenue ($m), USD Constant, 2021-2025 73

Table 46: PTCA Balloons Catheters Market, Mexico, Revenue ($m), USD Constant, 2015-2020 75

Table 47: PTCA Balloons Catheters Market, Mexico, Revenue ($m), USD Constant, 2021-2025 75

Table 48: Interventional Cardiology Market, Mexico, Volume (Units), 2015-2020 77

Table 49: Interventional Cardiology Market, Mexico, Volume (Units), 2021-2025 78

Table 50: Arteriotomy Closure Devices Market, Mexico, Volume (Units), 2015-2020 80

Table 51: Arteriotomy Closure Devices Market, Mexico, Volume (Units), 2021-2025 80

Table 52: Cardiac Catheters Market, Mexico, Volume (Units), 2015-2020 82

Table 53: Cardiac Catheters Market, Mexico, Volume (Units), 2021-2025 82

Table 54: Coronary Stents Market, Mexico, Volume (Units), 2015-2020 84

Table 55: Coronary Stents Market, Mexico, Volume (Units), 2021-2025 85

Table 56: Intravascular Ultrasound Systems (IVUS) Market, Mexico, Volume (Units), 2015-2020 87

Table 57: Intravascular Ultrasound Systems (IVUS) Market, Mexico, Volume (Units), 2021-2025 87

Table 58: PTCA Balloons Catheters Market, Mexico, Volume (Units), 2015-2020 89

Table 59: PTCA Balloons Catheters Market, Mexico, Volume (Units), 2021-2025 89

Table 60: Interventional Cardiology Market, Mexico, Average Price ($), 2015-2020 90

Table 61: Interventional Cardiology Market, Mexico, Average Price ($), 2021-2025 92

Table 62: Interventional Cardiology Market, Mexico, Distribution Share by Revenue ($m), USD Constant, 2017 94

Table 63: Interventional Cardiology Market, Mexico, Company Share by Revenue ($m), USD Constant, 2017 96

Table 64: Interventional Cardiology Market, United States, Revenue ($m), USD Constant, 2015-2020 98

Table 65: Interventional Cardiology Market, United States, Revenue ($m), USD Constant, 2021-2025 99

Table 66: Arteriotomy Closure Devices Market, United States, Revenue ($m), USD Constant, 2015-2020 101

Table 67: Arteriotomy Closure Devices Market, United States, Revenue ($m), USD Constant, 2021-2025 101

Table 68: Cardiac Catheters Market, United States, Revenue ($m), USD Constant, 2015-2020 103

Table 69: Cardiac Catheters Market, United States, Revenue ($m), USD Constant, 2021-2025 103

Table 70: Coronary Stents Market, United States, Revenue ($m), USD Constant, 2015-2020 105

Table 71: Coronary Stents Market, United States, Revenue ($m), USD Constant, 2021-2025 106

Table 72: Intravascular Ultrasound Systems (IVUS) Market, United States, Revenue ($m), USD Constant, 2015-2020 108

Table 73: Intravascular Ultrasound Systems (IVUS) Market, United States, Revenue ($m), USD Constant, 2021-2025 108

Table 74: PTCA Balloons Catheters Market, United States, Revenue ($m), USD Constant, 2015-2020 110

Table 75: PTCA Balloons Catheters Market, United States, Revenue ($m), USD Constant, 2021-2025 110

Table 76: Interventional Cardiology Market, United States, Volume (Units), 2015-2020 112

Table 77: Interventional Cardiology Market, United States, Volume (Units), 2021-2025 113

Table 78: Arteriotomy Closure Devices Market, United States, Volume (Units), 2015-2020 115

Table 79: Arteriotomy Closure Devices Market, United States, Volume (Units), 2021-2025 115

Table 80: Cardiac Catheters Market, United States, Volume (Units), 2015-2020 117

Table 81: Cardiac Catheters Market, United States, Volume (Units), 2021-2025 117

Table 82: Coronary Stents Market, United States, Volume (Units), 2015-2020 119

Table 83: Coronary Stents Market, United States, Volume (Units), 2021-2025 120

Table 84: Intravascular Ultrasound Systems (IVUS) Market, United States, Volume (Units), 2015-2020 122

Table 85: Intravascular Ultrasound Systems (IVUS) Market, United States, Volume (Units), 2021-2025 122

Table 86: PTCA Balloons Catheters Market, United States, Volume (Units), 2015-2020 124

Table 87: PTCA Balloons Catheters Market, United States, Volume (Units), 2021-2025 124

Table 88: Interventional Cardiology Market, United States, Average Price ($), 2015-2020 125

Table 89: Interventional Cardiology Market, United States, Average Price ($), 2021-2025 127

Table 90: Interventional Cardiology Market, United States, Distribution Share by Revenue ($m), USD Constant, 2017 129

Table 91: Interventional Cardiology Market, United States, Company Share by Revenue ($m), USD Constant, 2017 131

Table 92: Interventional Cardiology Market Pipeline Products 134

Table 93: Total Number of Primary Research Participants, Cardiovascular Devices Market, by Country 228

Figures

1.2 List of Figures

Figure 1: Interventional Cardiology Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2015-2025 15

Figure 2: Interventional Cardiology Market, North America, Revenue ($m), Historic, USD Constant, 2015-2025 17

Figure 3: Interventional Cardiology Market, North America, Volume (Units), 2015-2025 20

Figure 4: Interventional Cardiology Market, North America, Volume (Units), 2015-2025 22

Figure 5: Interventional Cardiology Market, North America, Company Share (%) 2017 25

Figure 6: Interventional Cardiology Market, Canada, Revenue ($m), USD Constant, 2015-2025 27

Figure 7: Arteriotomy Closure Devices Market, Canada, Revenue ($m), USD Constant, 2015-2025 30

Figure 8: Cardiac Catheters Market, Canada, Revenue ($m), USD Constant, 2015-2025 32

Figure 9: Coronary Stents Market, Canada, Revenue ($m), USD Constant, 2015-2025 34

Figure 10: Intravascular Ultrasound Systems (IVUS) Market, Canada, Revenue ($m), USD Constant, 2015-2025 37

Figure 11: PTCA Balloons Catheters Market, Canada, Revenue ($m), USD Constant, 2015-2025 39

Figure 12: Interventional Cardiology Market, Canada, Volume (Units), 2015-2025 41

Figure 13: Arteriotomy Closure Devices Market, Canada, Volume (Units), 2015-2025 44

Figure 14: Cardiac Catheters Market, Canada, Volume (Units), 2015-2025 46

Figure 15: Coronary Stents Market, Canada, Volume (Units), 2015-2025 48

Figure 16: Intravascular Ultrasound Systems (IVUS) Market, Canada, Volume (Units), 2015-2025 51

Figure 17: PTCA Balloons Catheters Market, Canada, Volume (Units), 2015-2025 53

Figure 18: Interventional Cardiology Market, Canada, Company Share (%) 2017 60

Figure 19: Interventional Cardiology Market, Mexico, Revenue ($m), USD Constant, 2015-2025 62

Figure 20: Arteriotomy Closure Devices Market, Mexico, Revenue ($m), USD Constant, 2015-2025 65

Figure 21: Cardiac Catheters Market, Mexico, Revenue ($m), USD Constant, 2015-2025 67

Figure 22: Coronary Stents Market, Mexico, Revenue ($m), USD Constant, 2015-2025 69

Figure 23: Intravascular Ultrasound Systems (IVUS) Market, Mexico, Revenue ($m), USD Constant, 2015-2025 72

Figure 24: PTCA Balloons Catheters Market, Mexico, Revenue ($m), USD Constant, 2015-2025 74

Figure 25: Interventional Cardiology Market, Mexico, Volume (Units), 2015-2025 76

Figure 26: Arteriotomy Closure Devices Market, Mexico, Volume (Units), 2015-2025 79

Figure 27: Cardiac Catheters Market, Mexico, Volume (Units), 2015-2025 81

Figure 28: Coronary Stents Market, Mexico, Volume (Units), 2015-2025 83

Figure 29: Intravascular Ultrasound Systems (IVUS) Market, Mexico, Volume (Units), 2015-2025 86

Figure 30: PTCA Balloons Catheters Market, Mexico, Volume (Units), 2015-2025 88

Figure 31: Interventional Cardiology Market, Mexico, Company Share (%) 2017 95

Figure 32: Interventional Cardiology Market, United States, Revenue ($m), USD Constant, 2015-2025 97

Figure 33: Arteriotomy Closure Devices Market, United States, Revenue ($m), USD Constant, 2015-2025 100

Figure 34: Cardiac Catheters Market, United States, Revenue ($m), USD Constant, 2015-2025 102

Figure 35: Coronary Stents Market, United States, Revenue ($m), USD Constant, 2015-2025 104

Figure 36: Intravascular Ultrasound Systems (IVUS) Market, United States, Revenue ($m), USD Constant, 2015-2025 107

Figure 37: PTCA Balloons Catheters Market, United States, Revenue ($m), USD Constant, 2015-2025 109

Figure 38: Interventional Cardiology Market, United States, Volume (Units), 2015-2025 111

Figure 39: Arteriotomy Closure Devices Market, United States, Volume (Units), 2015-2025 114

Figure 40: Cardiac Catheters Market, United States, Volume (Units), 2015-2025 116

Figure 41: Coronary Stents Market, United States, Volume (Units), 2015-2025 118

Figure 42: Intravascular Ultrasound Systems (IVUS) Market, United States, Volume (Units), 2015-2025 121

Figure 43: PTCA Balloons Catheters Market, United States, Volume (Units), 2015-2025 123

Figure 44: Interventional Cardiology Market, United States, Company Share (%) 2017 130

Frequently asked questions

North America Interventional Cardiology Market Outlook to 2025 standard reports
Currency USD
$5,995

Can be used by individual purchaser only

Most Popular
$11,990

Can be shared by unlimited users within one corporate location e.g. a regional office

$17,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Cardiovascular Devices reports
Medical Devices
New
PTA Peripheral DCB Catheters Pipeline by Development Stages, Segments, Region…
$4,000 | March 2024
Medical Devices
New
PCR Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | March 2024
Medical Devices
New
Immunochemistry Analyzers Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | March 2024
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at North America Interventional Cardiology Market Outlook to 2025 in real time.

  • Access a live North America Interventional Cardiology Market Outlook to 2025 dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more